Annual Shareholders Equity
-$1.76 M
-$2.74 M-279.23%
December 31, 2022
Summary
- As of February 10, 2025, BVXV annual stockholders equity is -$1.76 million, with the most recent change of -$2.74 million (-279.23%) on December 31, 2022.
- During the last 3 years, BVXV annual shareholders equity has risen by +$17.03 million (+90.63%).
Performance
BVXV Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Shareholders Equity
-$7.11 M
-$2.30 M-47.86%
June 30, 2023
Summary
- As of February 10, 2025, BVXV quarterly stockholders equity is -$7.11 million, with the most recent change of -$2.30 million (-47.86%) on June 30, 2023.
- Over the past year, BVXV quarterly shareholders equity has dropped by -$8.40 million (-652.69%).
Performance
BVXV Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
BVXV Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -279.2% | -652.7% |
| 3 y3 years | +90.6% | +60.4% |
| 5 y5 years | -110.9% | -255.7% |
BVXV Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -279.2% | at low | -239.9% | at low |
| 5 y | 5-year | -279.2% | +967.4% | -214.2% | +164.1% |
| alltime | all time | -110.9% | +967.4% | -136.6% | +185.3% |
BiondVax Pharmaceuticals Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | -$7.11 M(+47.9%) |
| Mar 2023 | - | -$4.81 M(+173.3%) |
| Dec 2022 | -$1.76 M(-279.2%) | -$1.76 M(-167.0%) |
| Sep 2022 | - | $2.63 M(+104.1%) |
| Jun 2022 | - | $1.29 M(-74.7%) |
| Mar 2022 | - | $5.08 M(+417.6%) |
| Dec 2021 | $982.00 K(-121.6%) | $982.00 K(-24.5%) |
| Sep 2021 | - | $1.30 M(-62.8%) |
| Jun 2021 | - | $3.50 M(-43.9%) |
| Mar 2021 | - | $6.23 M(-237.3%) |
| Dec 2020 | -$4.54 M(-75.8%) | -$4.54 M(+750.2%) |
| Sep 2020 | - | -$533.90 K(-97.0%) |
| Jun 2020 | - | -$17.96 M(+4.6%) |
| Mar 2020 | - | -$17.17 M(-8.6%) |
| Dec 2019 | -$18.79 M(+126.7%) | -$18.79 M(+220.3%) |
| Sep 2019 | - | -$5.87 M(-71.1%) |
| Jun 2019 | - | -$20.29 M(+140.6%) |
| Mar 2019 | - | -$8.43 M(+1.7%) |
| Dec 2018 | -$8.29 M | -$8.29 M(-306.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2018 | - | $4.02 M(-12.1%) |
| Jun 2018 | - | $4.57 M(-61.9%) |
| Mar 2018 | - | $12.00 M(-25.9%) |
| Dec 2017 | $16.18 M(+143.0%) | $16.18 M(-16.8%) |
| Sep 2017 | - | $19.45 M(+223.2%) |
| Jun 2017 | - | $6.02 M(-25.8%) |
| Mar 2017 | - | $8.11 M(+21.8%) |
| Dec 2016 | $6.66 M(-22.5%) | $6.66 M(-10.1%) |
| Sep 2016 | - | $7.41 M(-4.6%) |
| Jun 2016 | - | $7.76 M(-8.8%) |
| Mar 2016 | - | $8.51 M(-1.0%) |
| Dec 2015 | $8.59 M(+101.7%) | $8.59 M(-7.5%) |
| Sep 2015 | - | $9.29 M(-2.3%) |
| Jun 2015 | - | $9.51 M(+156.4%) |
| Mar 2015 | - | $3.71 M(-12.9%) |
| Dec 2014 | $4.26 M(-38.2%) | $4.26 M(-14.2%) |
| Sep 2014 | - | $4.97 M(-27.9%) |
| Dec 2013 | $6.89 M(+15.9%) | $6.89 M |
| Dec 2012 | $5.94 M | - |
FAQ
- What is BiondVax Pharmaceuticals annual stockholders equity?
- What is the all time high annual shareholders equity for BiondVax Pharmaceuticals?
- What is BiondVax Pharmaceuticals annual shareholders equity year-on-year change?
- What is BiondVax Pharmaceuticals quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for BiondVax Pharmaceuticals?
- What is BiondVax Pharmaceuticals quarterly shareholders equity year-on-year change?
What is BiondVax Pharmaceuticals annual stockholders equity?
The current annual shareholders equity of BVXV is -$1.76 M
What is the all time high annual shareholders equity for BiondVax Pharmaceuticals?
BiondVax Pharmaceuticals all-time high annual stockholders equity is $16.18 M
What is BiondVax Pharmaceuticals annual shareholders equity year-on-year change?
Over the past year, BVXV annual stockholders equity has changed by -$2.74 M (-279.23%)
What is BiondVax Pharmaceuticals quarterly stockholders equity?
The current quarterly shareholders equity of BVXV is -$7.11 M
What is the all time high quarterly shareholders equity for BiondVax Pharmaceuticals?
BiondVax Pharmaceuticals all-time high quarterly stockholders equity is $19.45 M
What is BiondVax Pharmaceuticals quarterly shareholders equity year-on-year change?
Over the past year, BVXV quarterly stockholders equity has changed by -$8.40 M (-652.69%)